Literature DB >> 23888097

A Combinatorial approach: To design inhibitory molecules on Hemagglutinin protein of H1N1 virus (Swine Flu).

Chekkara Venkata Satya Siva Prasad1, Kamal Kumar Chaudhary, Parul Dinkar.   

Abstract

The Hemagglutinin (HA) is a protein of influenza A virus. It is present on the surface of influenza A virus and it is a glycoprotein. The HA is identified as potential drug target. H1N1 thiazolides, proved to be a potent drug in the inhibition of H1N1 replication. It is also known as inhibitor of other strains of influenza A virus. Thiazolide drug represses viral HA's maturation at a level which exists just before the resistance from digestion of endoglycosidase-H and thereby it hampers, HA insertion in host membrane. Blocking the appropriate active site of hemagglutinin protein helps in the disease control. In the present work, we have generated diverse combinatorial library based ligands on known inhibitor thiazolides and they were used for virtual screening by Molegro virtual docker program. K-means clustering approach was used for finding new inhibitory molecules with more appropriate features. These resulted molecules are may be helpful in the treatment of swine flu and many other related diseases.

Entities:  

Keywords:  Hemagglutinin protein; Hydrogen bond interaction; K-means clustering; combinatorial library; virtual screening

Year:  2013        PMID: 23888097      PMCID: PMC3717184          DOI: 10.6026/97320630009565

Source DB:  PubMed          Journal:  Bioinformation        ISSN: 0973-2063


Background

The pandemic flu of influenza A viruses had caused deaths of millions of people Worldwide. It is proved in April 2009 that swine flu is contagious disease and it is spread from human to human [1]. Hemagglutinin (HA) protein of influenza A virus is a surface glycoprotein of virus [2]. Swine flu subtype H1N1 belongs to the Orthomyxoviridae influenza family of viruses [3]. There are 16 different HA antigens subtype present in swine flu [4]. These subtypes are labeled H1 through H16 (H1, H2, H3…H16) [5]. The structure of HA differs from strain to strain. HA occurs as mushroom shaped structure found on the virus surfaces and it is spread 135Å from the membrane [6]. The molecular size of HA is approximately 75kDa [7]. It is an antigenic glycoprotein and having capability for binding the cell of the host. HA glycoprotein binds to sialic acid receptors in the host's membrane cells [8]. After HA binds to these receptors, the viral membranes and cellular membranes are fuse, and the virus is taken entry into the cell with a small envelope of cellular membrane. According to the updates of WHO (2009 June 10) 27,737 cases of H1N1 had been reported among 74 different countries. The fatality rate of H1N1 is 0.4% (range 0.3%-1.5%) [9]. There are four drugs commonly used in the treatment of the above said disease, Amantadine and Rimantadine drugs worked by blocking the proton channel M2 and two drugs Zanamivir and Oseltamivir inhibit neuraminidase protein function [10]. These antiviral drugs are given to treat those people who become severely ill. Now a days it has been reported that thiazolide is a potent drug that inhibits the replication of swine flu virus by selectively blocking the maturation of HA, thereby it hampers HA by preventing its insertion in the host's membrane [11]. This study is basically aimed to develop new type of drug molecule for which, we used combinatorial library approach and K-means clustering approaches for finding drug like molecules. The newly designed drug molecules may help in the treatment of swine flu and many other related diseases.

Methodology

The structure of HA protein of swine flu H1N1 along with a ligands and water molecules were downloaded from RCSB Protein Data Bank (PDB ID: 1RUY in website http://www.rcsb.org/pdb) (Figure 1). 1RUY protein 3D molecules and anti drug molecule thiazolide were used for designing new inhibitor molecules. We took thiazolide as seed molecule and chemical structure was drawn using software ACD ChemSketch into as a mol file (Figure 2).
Figure 1

3D structure of Hemagglutinin protein (Pdb Code: 1RUY).

Figure 2

2D structure of Thiazolide.

Then mol file was converted into .sdf file by using Open Babel software. Combinatorial library designed by using known inhibitor thiazolide with the help of random library generation process [12]. For the high quality molecular diversity library generation, ILib diverse software was used [13]. This program was also designed for obtaining compound libraries with an optimal molecular diversity [14] in which molecules were filtered by using the Lipinski's rule of 5 which is the most approved filter for discernment between drug-like and non drug-like molecules [15]. For the conversion of 2D SDFile format into 3D SDFile format Corina software was used. It automatically generates three-dimensional atomic coordinates from the structure of a molecule and expresses it as a connection table or linear code, for large databases. The generated 3D library was used for virtual screening for finding new inhibitor for HA [16].

Molegro Virtual Docker:

Molegro Virtual Docker (MVD) is software for studying and predicting ligands interaction towards macromolecules. The docking performed by using flexible docking method of MVD [17]. Docking was performed for designed combinatorial library molecules on binding site of 1RUY protein.

K-mean clustering:

On the Top 200 molecules were taken from a combinatorial library in which these molecules having all information about molecular descriptor for K-means clustering purpose [18-19]. These molecules having many descriptors values such as log p value, hydrogen bond acceptor, hydrogen bond donor, topological polar surface area, rotatable bond count, rings numbers and molecular weight etc were calculated. Cluster these molecules by k-mean clustering algorithm. Two descriptors were selected in which molecular weight present on the X-axis and log p value present on the Y-axis. K-means clustering was done by Matlab.

Results & Discussion

The structure of HA was taken from protein data bank with the resolution of 2.70Å, R-factor of 0.248 and R-free: 0.265. Ramachandran plot analysis showed about 83.2% residues falling in the most favorable region, 15.2% residues falling in the allowed region and 1% generously allowed regions while 0.7% in the disallowed region.

Docking result of Thiazolide with 1RUY protein:

Figure 3b shows thiazolide drug molecule was docked with 1RUY protein, and the energy score comes out -77.5712KJ/mol. (Figure 3a) Illustrate the interaction between thiazolide and the active site of 1RUY. Thiazolide shows one hydrogen bond interaction within the active site of 1RUY. This hydrogen bond is donated by ligand molecule. Hydrogen bond energy of the protein-ligand complex is -1.13817. The residues that are distantly interacted with the ligand are Asp 585 was obtained by Molegro virtual docker.
Figure 3

a) Hydrogen bond interaction between Thiazolide and 1RUY; b) Possible binding site for Thiazolide drug in 1RUY

Residue involved in active site:

Possible binding site of 1RUY protein for design drug like top 10 ligands:

Molecule_1899:

In (Figure 4a), Molecule_1899 was docked with 1RUY protein, and giving the energy score of -169.672KJ/mol. In (Figure 4b), shows the hydrogen bond interaction between Molecule 1899 and the active site of 1RUY. Molecule_1899 shows four hydrogen bond interaction and one strong electrostatic interaction within the active site of 1RUY. All the four hydrogen bonds are donated by target molecule (1RUY). This proteinligand complex is having hydrogen bond energy of -5.01256.
Figure 4

a) Possible binding site for Molecule_1899 in 1RUY protein; b) Hydrogen bond interactions between Molecule_1899 and 1RUY

Molecule_1730:

In (Figure 5a), Molecule_1730 was docked with 1RUY protein, and giving the energy score -162.303KJ/mol. In (Figure 5b), Illustrate the interaction between Molecule_1730 and the active site of 1RUY. Molecule_1730 shows three hydrogen bond and two strong electrostatic interactions within the active site of 1RUY. All the three hydrogen bonds are donated by target molecule (1RUY) and is having hydrogen bond energy of - 5.20299.
Figure 5

a) Possible binding site for Molecule_1730 in 1RUY protein; b) Hydrogen bond interactions between Molecule_1730 and 1RUY

Molecule_4488:

In (Figure 6a), Molecule_4488 was docked with 1RUY protein, and giving the energy score of -161.455 KJ/mol. In (Figure 6b), it illustrates the interaction between Molecule_4488 and the active site of 1RUY. Molecule_4488 shows four hydrogen bond and two strong electrostatic interactions within the active site of 1RUY. Out of four hydrogen bonds, two hydrogen bonds are donated by target molecule and the remaining two hydrogen bonds are donated by ligand molecule. Hydrogen bond energy of the protein-ligand complex is -6.41833. These ten molecules having the high negative energy score compare to thiazolide molecule were docked with 1RUY protein. These ten molecules had energy scores ranging from -151.601 to -169.672KJ/mol
Figure 6

a) Possible binding site for Molecule_4488 in 1RUY protein; b) Hydrogen bond interactions between Molecule_4488 and 1RUY

Clustering result:

K-means clustering approach used in a top 200 molecules of combinatorial library were found assign five clusters [12]. For each cluster two molecules were represented in all clusters centroid. Which are nearest to the cluster centroid. For k-means clustering were selected descriptors molecular weight and log p value. Select top five ligands which were found from virtual screening by using Molegro program had energy scores ranging from -90.893 to -120.842KJ/mol.

Molecule_45:

In (Figure 7a) Molecule_45 was docked with 1RUY protein, and giving the energy score -120.842KJ/mol. In (Figure 7b), Illustrate the interaction between Molecule_45 and the active site of 1RUY. Molecule_45 shows one hydrogen bond interactions within the active site of 1RUY. This hydrogen bond is donated by target molecule (1RUY) and energy of this hydrogen bond is -0.328907.
Figure 7

a) Possible binding site for Molecule_45 in 1RUY protein; b) Hydrogen bond interaction between Molecule_45.

Molecule_77:

In (Figure 8a), Molecule_77 was docked with 1RUY protein, and giving the energy score -106.101 KJ/mol. In (Figure 8b), it illustrates the interaction between Molecule_77 and the active site of 1RUY. Molecule_77 shows five hydrogen bond interactions within the active site of 1RUY. All five hydrogen are donated by target molecule (1RUY). Hydrogen bond energy of this protein-ligand complex is -5.17897.
Figure 8

a) Possible binding site for Molecule_1779 in 1RUY protein, b) Hydrogen bond interactions between Molecule_77 and 1RUY.

Molecule_35:

Figure 9a Molecule_35 was docked with 1RUY protein, and giving the energy score -92.996KJ/mol. In (Figure 9b), it illustrate the interaction between Molecule_35 and the active site of 1RUY. Molecule_35 shows 2 hydrogen bond interactions within the active site of 1RUY. All the hydrogen bonds are donated by target molecule (1RUY). The hydrogen bond interaction energy of this protein-ligand complex is -0.517533. After docking, the above said top five molecules were found with better energy scores comparison the energy score of thiazolide drug molecule.
Figure 9

a) Possible binding site for Molecule_35 in 1RUY protein; b) Hydrogen bond interactions between Molecule_35 and 1RUY.

The structure of hemagglutinin (HA) protein along with ligands and water molecules are taken from PDB (PDB Code: 1RUY) [20]. To prevent H1N1 replication thiazolide, proved to be a potent drug. Thiazolide drug represses viral HA's maturation at a level which exists just before the resistance from digestion of endoglycosidase-H and thereby it hampers HA preventing its insertion in host membrane. Hence we have used this protein structure for virtual screening to find out thiazolide specific new inhibitors [21]. We first built a diverse combinatorial library of 5000 molecules by incorporating the features of known inhibitor [22]. This library was pruned by using Lipinski rule of 5 [23]. Each compound was automatically docked into the binding region of protein and given a score. These scores were given by the quality of fitting compound to the target site. So after careful docking generated more ligands in which top 10 ranking ligands displaying the lowest predicted energy were selected. These molecules having more negative energy score (KJ/mol). After docking of thiazolide antidrug molecules with 1RUY, the energy score was found to be -77.5712 KJ/mol. Top ten ligands which were found from docking had energy scores ranging from -151.601 to -169.672 KJ/mol. These 10 molecules had better energy compare to thiazolide energy score in Table 2 (see supplementary material). Then we checked the hydrogen bond interaction between 1RUY protein and top10 molecules were obtained by Molegro virtual docker. K-means clustering approach was used for finding more new inhibitor by virtual screening. After this process top 5 ligands were selected. These 5 molecules had energy score ranging from -90.893 to -120.842 KJ/mol. These molecules had also high negative energy compare to thiazolide, in Table 2 (see supplementary material). Then we had checked the hydrogen bond interaction between 1RUY protein and top 5 molecules. More negative the energy score (KJ/mol) more is the binding affinity. These new ligands molecules will help for the prevention of swine flu and many other related diseases.

Conclusion

It was found that drug like molecules for the inhibition of hemagglutinin, thiazolides antidrug molecule play an important role for designing a new novel drug like molecules. The structure of HA (PDB Code: 1RUY) was considered as target receptor. HA protein was used for virtual screening for generating new ligands. These ligands having better energy scores than known inhibitor thiazolides by generated diverse combinatorial library ILib diverse and docking based virtual screening of this library by using the Molegro Virtual Docker program. In which top 10 ligands having better energy scores compared to thiazolide. K-mean-clustering approach was also used and found top five molecules having energy ranging from -90.893 to -120.842 KJ/mol. Energies of these molecules were also high in compare to thiazolide. These ligands may function as a potent and specific inhibitor for HA and will help the prevention of swine flu and other related diseases.
  9 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Computational methods for the prediction of 'drug-likeness'

Authors: 
Journal:  Drug Discov Today       Date:  2000-02       Impact factor: 7.851

3.  Protein ligand docking based on empirical method for binding affinity estimation.

Authors:  P Tao; L Lai
Journal:  J Comput Aided Mol Des       Date:  2001-05       Impact factor: 3.686

4.  Compounds designed to fit a site of known structure in human haemoglobin.

Authors:  C R Beddell; P J Goodford; F E Norrington; S Wilkinson; R Wootton
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

Review 5.  Computational studies of influenza A virus at three important targets: hemagglutinin, neuraminidase and M2 protein.

Authors:  Thanyada Rungrotmongkol; Pathumwadee Yotmanee; Nadtanet Nunthaboot; Supot Hannongbua
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin.

Authors:  Manabu Igarashi; Kimihito Ito; Reiko Yoshida; Daisuke Tomabechi; Hiroshi Kida; Ayato Takada
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

7.  Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries.

Authors:  Arun K Kashyap; John Steel; Adam Rubrum; Angeles Estelles; Raffaella Briante; Natalia A Ilyushina; Li Xu; Ryann E Swale; Aleksandr M Faynboym; Pamela K Foreman; Michael Horowitz; Lawrence Horowitz; Richard Webby; Peter Palese; Richard A Lerner; Ramesh R Bhatt
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

8.  Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion.

Authors:  Rupert J Russell; Philip S Kerry; David J Stevens; David A Steinhauer; Stephen R Martin; Steven J Gamblin; John J Skehel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

Review 9.  Influenza A virus entry inhibitors targeting the hemagglutinin.

Authors:  Jie Yang; Minmin Li; Xintian Shen; Shuwen Liu
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.